脑死亡的代谢模式 - - 脑脊液的基于NMR的代谢学
Beata Toczylowska1, Piotr Kalinowski2, Agata Kacka-Piotrowska3
1Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, 4 Trojdena Street, 02-109 Warsaw, Poland.
International journal of molecular sciences
|March 27, 2025
概括
大脑脊髓液 (CSF) 的代谢概况,而不是单个标记,可以区分大脑死亡和正常状态. 与对照人群相比,NMR光谱学揭示了脑死亡患者的CSF中显著的生物化学差异.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 医学诊断 医学诊断 医学诊断
背景情况:
- 脑死亡诊断依赖于临床标准,但脑脊液 (CSF) 中的生化标志物仍未得到充分研究.
- 了解CSF生化变化对于生命支持患者至关重要,因为临床评估可能具有挑战性.
研究的目的:
- 用NMR光谱学研究脑死患者中脑脊液 (CSF) 的生物化学概况.
- 识别潜在的CSF生物标志物,区分大脑死亡与正常神经状态.
主要方法:
- 来自22名脑死亡患者和34名对照者的脑脊髓液 (CSF) 样本使用体外NMR光谱学进行了分析.
- 应用了包括ANOVA和区分分析在内的单变量和多变量统计方法来分析41个来自原始CSF的NMR信号和20个来自脂质提取物的NMR信号.
主要成果:
- 在脑死亡患者和对照人群之间,在所有分析的CSF信号中观察到显著差异.
- 没有单一的生化标志物可靠地预测大脑死亡;然而,确定了不同的代谢概况.
- 关键的不同化合物包括氨基酸,乳酸盐,酸盐,酸盐,胆和胆固醇和雌醇等脂质.
结论:
- 脑脊液 (CSF) 的代谢概况,而不是单个生物标志物,有效地区分脑死亡.
- 脑脊液的NMR光谱显示了显著的生化变化,表明大脑死亡,有助于诊断.
更多相关视频
09:01Metabolomic Analysis of Rat Brain by High Resolution Nuclear Magnetic Resonance Spectroscopy of Tissue Extracts
Published on: September 21, 2014
14.7K
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
420
相关概念视频
01:25Applications Of NMR In Biology
Nuclear magnetic resonance (NMR) spectroscopy is a very valuable analytical technique for researchers. It has been used for more than 50 years as an analytical tool. F. Bloch and E. Purcell formulated NMR in 1946 and won the 1952 Nobel Prize in Physics for their work. Biological macromolecules such as proteins, nucleic acids, lipids, and organic molecules including pharmaceutical compounds, can be studied using this versatile tool that exploits the magnetic properties of certain nuclei.
The...
The...
01:24Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...